- Home » News and EventsPage 16
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Updates for media on the latest products, offerings and developments across our business.
Press Releases
Catalent to Discuss Innovative Approaches to Achieving T-Cell Commercial Readiness at Upcoming Industry Conference
Oct 12, 2020
Catalent today announced that Jesse Trekker, Ph.D., Business Director, Strategic Partnerships, Catalent Cell & Gene Therapy, will present at the Allogeneic Cell Therapies Summit, which will take place virtually on 26 – 28 October, 2020.
Innovation in Oncology, Cell & Gene Technology, and Post-COVID-19 Pharma Outlook to be Discussed by Catalent at CPhI
Oct 6, 2020
Catalent today announced that it will be participating in several roundtables alongside other leading industry experts at the CPhI Festival of Pharma, which is taking place virtually between Oct. 5 – 16, 2020.
Catalent Launches OneXpress® Solution to Accelerate Oral Dosage Products from Clinic to Launch
Oct 1, 2020
Catalent today announced the launch of its new OneXpress® service for the integrated development, scale up and manufacturing of new oral solid dosage forms.
Catalent Wins Scottish Engineering Vice President Award for Excellence
Oct 1, 2020
Catalent’s clinical supply site in Bathgate has won Scottish Engineering’s ‘Vice President Award 2020,’ recognising its continuous improvement programme in core values including “patient first, customer dedication, people, innovation, integrity and excellence.”
Catalent Supports Rapid Development and Supply of Nocion Therapeutics’ Clinical Trial Materials for Acute and Chronic Cough Using Blow-Fill-Seal Technology
Sep 28, 2020
Catalent today welcomed the news from Nocion Therapeutics, Inc., a biopharmaceutical company developing novel small molecule charged sodium channel blockers, that its first patient has been dosed with NOC-100, an inhaled formula of its NTX-1175 small molecule candidate.
Catalent Acquires New Biologics Facility to Create North American Clinical Manufacturing Center of Excellence
Sep 24, 2020
Catalent today announced that it has acquired a new manufacturing facility in Bloomington, Indiana, to create a North American center of excellence for early-phase clinical biologics formulation development and drug product fill/finish services.
Advantages of Oncolytic Viruses as Immunotherapies to be Discussed by Catalent Gene Therapy Expert
Sep 22, 2020
Catalent today announced that George Buchman, Ph.D., Vice President, Preclinical & Process Development, will present at the World Vaccine Congress, which will take place virtually on Sept. 28 – October 1, 2020.
T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy
Sep 21, 2020
T-knife and Catalent today announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor (TCR) program.
Catalent Biologics and Humanigen to Present a Case Study on Accelerated Scale Up of a Monoclonal Antibody to Treat COVID-19 at BioProcess International Conference
Sep 16, 2020
Catalent today announced that it will present at the upcoming BioProcess International virtual conference, taking place between Sept. 21 – 25, 2020.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.